NBC News: Queer the Ballet Is Trying to Fix National Crisis of Scarcity...
Reid Wiseman Moved to Tears At Sight of the Cross
Newsweek: Student Self-Deports After Enduring ‘Inhumane’ ICE Conditions
Mayor Brandon Johnson Talks Reparations, Says Restaurant Industry Has Vestiges in Slavery
The Other Shoe Drops: Anna Paulina Luna Reports Sexual Misconduct Allegations Against Rube...
Once Fine Blokes, Now Just Broke: UK Would Be the Poorest State in...
Pope Leo: "Woe to Those Who Manipulate Religion … For Their Own Military...
Judge Again Blocks Construction of White House Ballroom, Says Bunker Can Proceed
Whoopi Goldberg Schools People Who Think They Know the Bible-Bible
Trump Calls Out Pope’s Selective Silence: 'Tell That to the Pope' on Iran...
Variety: Pete Hegseth Tried to Evoke Scripture but Quoted ‘Pulp Fiction’ Instead
Hennepin County Attorney Issues Nationwide Arrest Warrant for ICE Agent for Assault
People Can't Help but Notice Where Kamala Harris Did NOT Record Her 'Gas...
HRM: Deadbeat Jerks at The Lincoln Project Have Some 'Splainin' to Do About...
Antisemites UNITE! Ilhan Omar Praises Candace Owens and I'd Only Be More Surprised...

Christina Pushaw busts the AP for acknowledging a COVID treatment fact they shamed Ron DeSantis for pointing out just a few months ago

Yesterday, the Associated Press’ Matthew Perrone reported a possible setback for a couple of COVID19 treatments, including Regeneron.

Advertisement

More from the AP:

As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain.

For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital.

But both drugmakers recently warned that laboratory testing suggests their therapies will be much less potent against omicron, which contains dozens of mutations that make it harder for antibodies to attack the virus. And while the companies say they can quickly develop new omicron-targeting antibodies, those aren’t expected to launch for at least several months.

The fact that Regeneron may not be as effective against the omicron variant as it’s been against others is noteworthy enough. But Gov. Ron DeSantis’ press secretary Christina Pushaw finds something else noteworthy, too:

Things sure have changed, haven’t they? Recall this past August, when the AP was entertaining the idea that DeSantis was promoting sketchy Regeneron in some kind of quid pro quo scheme because one of his top donors had invested money in Regeneron, making DeSantis shady AF and not to be trusted.

Advertisement

Pushaw called out the AP then.

Just like she’s calling out the AP now.

We’ve got whiplash.

And Pushaw’s got one last question for the AP:

Join the conversation as a VIP Member

Recommended

Trending on Twitchy Videos

Advertisement
Advertisement
Advertisement